• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.13% Nasdaq Up 0.14%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    10.69 Down 0.47(4.21%) May 26, 4:00PM EDT
    |After Hours : 10.69 Down 0.00 (0.02%) May 26, 4:31PM EDT
    Prev Close:11.16
    Open:11.24
    Bid:10.69 x 2000
    Ask:11.30 x 500
    1y Target Est:15.50
    Beta:2.90616
    Earnings Date:Aug 8 - Aug 12 (Est.)
    Day's Range:10.66 - 11.26
    52wk Range:4.50 - 11.69
    Volume:1,318,083
    Avg Vol (3m):1,735,440
    Market Cap:781.41M
    P/E (ttm):N/A
    EPS (ttm):-0.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INODown 4.21%781.41M
    PFEUp 0.23%208.81B
    AZNDown 0.10%75.77B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):18.75
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.75
    Quarterly EPS Est (Jun-16) :-0.21
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback